I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Background Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory
condition of the upper airways. Optimal management is unclear. Objective We compared the …

Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of
chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that …

Aspirin-Exacerbated Respiratory Disease About 7% of patients with asthma have mucosal
swelling, nasal polyps, and worsening of asthma in response to aspirin and other COX-1 …

The nonsteroidal anti‐inflammatory agent aspirin is widely used for preventing and treating
cardiovascular and cerebrovascular diseases. In addition, epidemiologic evidences reveal …

Background Chronic rhinosinusitis with nasal polyposis (CRSwNP) in the setting of aspirin‐
exacerbated respiratory disease (AERD) is a disease that is difficult to treat and prone to …

Aspirin-exacerbated respiratory disease (AERD) is a late onset condition characterized by
the Samter triad (aspirin sensitivity [as well as sensitivity to any nonselective …

Background Aspirin-exacerbated respiratory disease (AERD) affects 7% of asthmatics.
Usual therapies are inadequate for asthma and/or nasal polyposis, leading to decreased …

Objective: The large amount of evidence and the renewed interest in upper and lower
airways involvement in infectious and inflammatory diseases has led Interasma (Global …